The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Chlamydia pneumoniae and Chlamydial Heat Shock Protein 60 Stimulate Proliferation of Human Vascular Smooth Muscle Cells via Toll-Like Receptor 4 and p44/p42 Mitogen-Activated Protein Kinase Activation
Open accessAbstract
An early component of atherogenesis is abnormal vascular smooth muscle cell (VSMC) proliferation. The presence of Chlamydia pneumoniae in many atherosclerotic lesions raises the possibility that this organism plays a causal role in atherogenesis. In this study, C pneumoniae elementary bodies (EBs) rapidly activated p44/p42 mitogen-activated protein kinases (MAPKs) and stimulated proliferation of VSMCs in vitro. Exposure of VSMCs derived from human saphenous vein to C pneumoniae EBs (3×10 7 inclusion forming units/mL) enhanced bromodeoxyuridine (BrdU) incorporation 12±3-fold. UV- and heat-inactivated C pneumoniae EBs also stimulated VSMC proliferation, indicating a role of direct stimulation by chlamydial antigens. However, the mitogenic activity of C pneumoniae was heat-labile, thus excluding a role of lipopolysaccharide. Chlamydial hsp60 (25 μg/mL) replicated the effect of C pneumoniae , stimulating BrdU incorporation 7±3-fold. Exposure to C pneumoniae or chlamydial hsp60 rapidly activated p44/p42 MAPK, within 5 to 10 minutes of exposure. In addition, PD98059 and U0126, which are two distinct inhibitors of upstream MAPK kinase 1/2 (MEK1/2), abolished the mitogenic effect of C pneumoniae and chlamydial hsp60. Toll-like receptors (TLRs) act as sensors for microbial antigens and can signal via the p44/p42 MAPK pathway. Human VSMCs were shown to express TLR4 mRNA and protein, and a TLR4 antagonist abolished chlamydial hsp60–induced VSMC proliferation and attenuated C pneumoniae –induced MAPK activation and VSMC proliferation. Together these results indicate that C pneumoniae and chlamydial hsp60 are potent inducers of human VSMC proliferation and that these effects are mediated, at least in part, by rapid TLR4-mediated activation of p44/p42 MAPK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,015
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Self-citationOhashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
Caldwell, H. D., Kromhout, J. P., & Schachter, J. (1981) · Infection and Immunity · doi:10.1128/iai.31.3.1161-1176.1981 · Cited by 1,053
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products
Lien, E., Sellati, T. J., Yoshimura, A., Flo, T. H., Rawadi, G., Finberg, R. W., Carroll, J. D., Espevik, T., Ingalls, R. R., Radolf, J. D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33419 · Cited by 918
Self-citationToll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
Underhill, D. M., Ozinsky, A., Smith, K. D., & Aderem, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14459 · Cited by 827
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
Lien, E., Means, T. K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., Fenton, M. J., Oikawa, M., Qureshi, N., Monks, B., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8541 · Cited by 727
Self-citationHirschfeld, M., Kirschning, C. J., Schwandner, R., Wesche, H., Weis, J. H., Wooten, R. M., & Weis, J. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2382 · Cited by 657
Zhang, F. X., Kirschning, C. J., Mancinelli, R., Xu, X.-P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., & Arditi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7611 · Cited by 595
Faure, E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., Kirschning, C. J., Polentarutti, N., Muzio, M., & Arditi, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11058 · Cited by 560
Kol, A., Lichtman, A. H., Finberg, R. W., Libby, P., & Kurt-Jones, E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.13 · Cited by 554
Kol, A., Sukhova, G. K., Lichtman, A. H., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.98.4.300 · Cited by 538
Kol, A., Bourcier, T., Lichtman, A. H., & Libby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5310 · Cited by 510
Beatty, W. L., Byrne, G. I., & Morrison, R. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3998 · Cited by 466
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.
Shor, A., Kuo, C. C., & Patton, D. L. (1992) · PubMed · Cited by 455
Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A., & Quinn, T. C. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1614-1620.1996 · Cited by 442
Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.
Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., & Raetz, C. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55023-7 · Cited by 416
Self-citationDetection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.
Kuo, C. C., Gown, A. M., Benditt, E. P., & Grayston, J. T. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1501 · Cited by 349
Cleveland, M. G., Gorham, J. D., Murphy, T. L., Tuomanen, E., & Murphy, K. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.1906-1912.1996 · Cited by 319
Flo, T. H., Halaas, Ø., Lien, E., Ryan, L., Teti, G., Golenbock, D. T., Sundan, A., & Espevik, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2064 · Cited by 282
Self-citationCellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4
Yang, H., Young, D. W., Gusovsky, F., & Chow, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002896200 · Cited by 269
The biology of Toll-like receptors
Means, T. K., Golenbock, D. T., & Fenton, M. J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00006-x · Cited by 267
Self-citationMAP kinase-mediated signalling to nucleosomes and immediate-early gene induction
Thomson, S., Mahadevan, L. C., & Clayton, A. L. (1999) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.1999.0302 · Cited by 226
Jackson, L. A., Campbell, L. A., Schmidt, R. A., Kuo, C. C., Cappuccio, A., Lee, M. J., & Grayston, J. T. (1997) · Europe PMC (PubMed Central) · Cited by 206
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated
Ingalls, R. R., Rice, P. A., Qureshi, N., Takayama, K., Lin, J. S., & Golenbock, D. T. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.3125-3130.1995 · Cited by 197
Self-citationAqel, N. M., Ball, R. Y., Waldmann, H., & Mitchinson, M. J. (1985) · The Journal of Pathology · doi:10.1002/path.1711460306 · Cited by 189
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
Godzik, K. L., O'Brien, E. R., Wang, S. K., & Kuo, C. C. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2411-2414.1995 · Cited by 189
Kalayoglu, M. V., & Byrne, G. I. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5067-5072.1998 · Cited by 188
Cellular Oxidation of Low‐Density Lipoprotein byChlamydia pneumoniae
Kalayoglu, M. V., Hoerneman, B., LaVerda, D., Morrison, S. G., Morrison, R. P., & Byrne, G. I. (1999) · The Journal of Infectious Diseases · doi:10.1086/314931 · Cited by 154
Self-citationDistribution ofChlamydia pneumoniaeInfection in the Atherosclerotic Carotid Artery
Yamashita, K., Ouchi, K., Shirai, M., Gondo, T., Nakazawa, T., & Ito, H. (1998) · Stroke · doi:10.1161/01.str.29.4.773 · Cited by 126
Kashiwada, M., Shirakata, Y., Inoue, J., Nakano, H., Okazaki, K., Okumura, K., Yamamoto, T. S., Nagaoka, H., & Takemori, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.237 · Cited by 125
Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae.
Leinonen, M. (1993) · PubMed · Cited by 121
Netea, M. G., Selzman, C. H., Kullberg, B. J., Galama, J. M. D., Weinberg, A., Stalenhoef, A. F. H., van der Meer, J. W. M., & Dinarello, C. A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200002)30:2<541::aid-immu541>3.0.co;2-x · Cited by 109
Temperature-controlled radiofrequency catheter ablation of AV conduction: first clinical experience
Hoffmann, E., MATTKE, S., Dorwarth, U., Müller, D. N., Haberl, R., & Steinbeck, G. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.1.57 · Cited by 84
Chlamydia pneumoniae in atheroma: consideration of criteria for causality.
Shor, A., Phillips, J. I., Ong, G., Thomas, B. J., & TAYLOR‐ROBINSON, D. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.11.812 · Cited by 53
Chlamydia pneumoniae and Atherosclerosis
Shor, A. (1999) · JAMA · doi:10.1001/jama.282.21.2071 · Cited by 46
Vehmaan-Kreula, P., Puolakkainen, M. H., Sarvas, M., Welgus, H. G., & Kovanen, P. T. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.e1 · Cited by 44
Atherogenetically Relevant Cells Support Continuous Growth of Chlamydia Pneumoniae
Maass, M., Gieffers, J., & Solbach, W. (2000) · Herz · doi:10.1007/pl00001953 · Cited by 13
Cited by
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Roles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Toll-like receptors: key mediators of microbe detection
Underhill, D. M., & Ozinsky, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00304-1 · Cited by 681
Henderson, B., & Martin, A. (2011) · Infection and Immunity · doi:10.1128/iai.00179-11 · Cited by 458
Metadata
- Authors
- Sasu, S., LaVerda, D., Qureshi, N., Golenbock, D. T., & Beasley, D.
- Venue
- Circulation Research
- Published
- 2001-08-03
- Volume
- 89
- Issue
- 3
- Pages
- 244-250
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2155983915
- Cited by
- 278
- References
- 40
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.